Literature DB >> 3334164

Protein degradation: the role of mixed-function oxidases.

V Daggett1.   

Abstract

The mechanisms by which protein oxidation is mediated in the cell are of both biological and pharmacological importance. Oxidases responsible for the metabolism of xenobiotics catalyze the oxidative inactivation of select enzymes. Oxidation mediated by mixed-function oxidase (MFO) systems renders proteins more susceptible to proteolysis and, consequently, appears to be a signal for protein degradation. The mode of action of MFO systems is discussed in detail for a specific, well-characterized system--the MFO-catalyzed oxidation of glutamine synthetase (GS). Findings for this system are then generalized to help explain how other metabolic enzymes are oxidized by MFO systems. The broader consequences of oxidative mechanisms are discussed. For example, the accumulation of modified proteins during aging and in some premature aging diseases may be due in part to shifts in the relative rates of oxidation and degradation for these proteins. Further, the oxidation of key metabolic enzymes appears to be responsible for the bacteriocidal action of neutrophils. There is also some evidence that the degradation of endogenous proteins increases following ingestion of, or exposure to, agents that induce MFO activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3334164     DOI: 10.1023/a:1016484901485

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

1.  The maintenance of the accuracy of protein synthesis and its relevance to ageing.

Authors:  L E ORGEL
Journal:  Proc Natl Acad Sci U S A       Date:  1963-04       Impact factor: 11.205

2.  Relationship between in vivo degradative rates and isoelectric points of proteins.

Authors:  J F Dice; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

3.  Equilibrium and kinetic studies of unfolding of homologous cytochromes c.

Authors:  G McLendon; M Smith
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

4.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 5.  Ageing of clones of mammalian cells.

Authors:  L E Orgel
Journal:  Nature       Date:  1973-06-22       Impact factor: 49.962

6.  Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue.

Authors:  R L Levine
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

Review 7.  Active oxygen species and the functions of phagocytic leukocytes.

Authors:  J A Badwey; M L Karnovsky
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

8.  The role of superoxide in the destruction of erythrocyte targets by human neutrophils.

Authors:  S J Weiss
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

9.  Reaction of Bacillus subtilis glutamine phosphoribosylpyrophosphate amidotransferase with oxygen: chemistry and regulation by ligands.

Authors:  D A Bernlohr; R L Switzer
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

10.  Phagocytosing human neutrophils inactivate their own granular enzymes.

Authors:  A A Voetman; R S Weening; M N Hamers; L J Meerhof; A A Bot; D Roos
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  2 in total

Review 1.  The role of pharmacokinetics in the development of biotechnologically derived agents.

Authors:  R J Wills; B L Ferraiolo
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Pharmacological Vitamin C Treatment Impedes the Growth of Endogenous Glutamine-Dependent Cancers by Targeting Glutamine Synthetase.

Authors:  Yali Long; Jia Qiu; Bing Zhang; Peng He; Xinchong Shi; Qiao He; Zhifeng Chen; Wanqing Shen; Zhoulei Li; Xiangsong Zhang
Journal:  Front Pharmacol       Date:  2021-05-11       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.